Biopharma Automation & AI
Genedata empowers biopharma organizations worldwide with first-in-class enterprise software to innovate boldly, operate efficiently, and accelerate discovery, development, and manufacturing of next-generation medicines.
Genedataは1997年の創業以来、バイオ医薬品の研究開発におけるイノベーションを後押ししてきました。"Genedata Biopharma Platform"は、研究開発プロセスをデジタル化し、スループットとデータ品質を向上することで、研究開発ワークフロー全体を効率化します。
Our Customers
One Data Model
A single, unified data model powering collaboration and innovation
Science-Native
Developed by scientists for scientists, in collaboration with industry leaders
Automation & AI
Automated workflows and embedded AI turning data into intelligence
Proven Solution
Trusted for 25+ years by leading biopharma innovators worldwide
Off-the-Shelf
Ready-to-use and fast to deploy on-premises or SaaS
User Friendly
Complex workflows and stringent standards made easy and intuitive
Future-Proof
Open, scalable, and built on modern technology with compliance at its core
Maximum ROI
Highest value realization, year-over-year, reported by our customers
Automation & AI. Biopharma Reimagined.
Automation and AI are key to driving innovation, increasing efficiency, reducing costs and mitigating risk. They are not optional anymore. Genedata has a deep understanding of the complex biopharma R&D workflows, the data, and how it’s used across modalities. We are combining our expertise with a unified, structured data foundation, advanced automation technology and embedded AI to empower our customers to accelerate data workflows, increase scientific productivity, uncover hidden insights and enable scientific breakthrough.
Genedata Webinar Week
June 2026
In the fourth edition of Genedata Webinar Week, global biopharma experts shared how automation of laboratory and data workflows is enabling faster, smarter, and more scalable R&D. Each session offered real-world case studies on how leading teams are accelerating complex analytics, improving data accuracy, and driving innovation with the Genedata Biopharma Platform.
Novartis Wins Bio-IT World 2026 Innovative Practice Award for Real-World AI with Genedata Vico
We are proud to celebrate Novartis as the recipient of this prestigious award. This recognition highlights Vico’s AI‑native approach to transforming CMC data management and governance at enterprise scale, empowering compliance‑ready decisions with confidence and accelerating development timelines.
Delivered. On Time. Compliant.
Biopharma companies cannot afford wasting their time to achieve operational efficiency and minimize time to patient . This is why we deliver the solutions they need, and we deliver them on time, always. And our customers have to minimize compliance and quality risks to comply with regulations and to deliver medicines of high quality, safety and efficacy to their patients. This is why we provide a platform with data integrity, traceability, and compliance, built-in by design.
Genedata Partner Symposium 2025
第11回 Genedata Partner Symposiumより、イベントレポートをお届けします。
今回、250名を超える研究者やITのプロフェッショナルに参加いただきました。出席企業には、AstraZeneca・Gilead・Novartis・Sanofi・Moderna・Pfizer・AbbVie・Novo Nordisk, Biogen・Astellas・J&J・Amgen・Daiichi Sankyo・Takeda・Boehringer Ingelheim・GSKが含まれます。
Expert-Led. Insight-Driven.
Stay ahead with practical insights from leading voices in biopharma at Genedata Webinar Week, a recurring multi-day virtual event. Across expert-led sessions, industry leaders share real-world strategies, applied use cases, and guidance on the technologies transforming modern R&D.
We undertook a thorough selection process to find the best antibody workflow platform and Genedata was the obvious choice.
One of the reasons we chose Genedata was the platform’s process coverage. We required that the full diversity of Pfizer’s large-molecule processes and technologies be supported by one integrated system.
We needed a central platform to capture and process data across our global R&D teams, while ensuring full data integrity and traceability, and Genedata was the only solution that ticked all the boxes right from the start.
